- Bedoelde u
- medicines use
Zoekresultaten - 5 results
P142 Review of diagnostic labels for patients with unconfirmed cystic fibrosis diagnosis using registry data
https://doi.org/10.1016/S1569-1993(23)00517-9 Full text language: English Category: C33 FOS Classification: 3.02 Clinical medicine ...
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis. RESULTS: Up to December 31, 2020, 26 countries reported information on ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
a facilitating factor for ABPA. ABPA causes a significant increase in bronchial damage. In patients with ABPA, further bronchial damage can be controlled by an increase in hospitalization days and use of IV ...
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.
American registry analysis in cystic fibrosis (CF) children showed less lung function decline after starting inhaled corticosteroid (ICS) use. We therefore examined the influence of ICS treatment on lung ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
regression was used to investigate factors associated with clinical progression to severe COVID-19, using the primary outcome of hospitalisation with supplemental oxygen. RESULTS: SARS-CoV-2 was reported in ...